Oxford Nanopore Technologies PLC at Morgan Stanley Global Healthcare Conference Transcript
Hey, everyone. Good afternoon. My name is Tejas Savant. I'm the life science tools and diagnostics analyst here at Morgan Stanley. Before we get started for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.
It's my pleasure this afternoon to host Oxford Nanopore and from the company, we have Gordon Sanghera, CEO. I know, Gordon, you want to make some opening remarks and introduce all the shiny toys you've brought with you. So take it away and then we'll get into Q&A.
Thanks, Tejas, and good afternoon, everybody. I might be the last person between you and the drink this evening. Hopefully, we can entertain you. I have here some toys, indeed. I have some sequences, actually, nanopore sequences, and I'll start with MinION, which Oxford Nanopore was formed in 2005 and was launched 10 years later, and it is a small portable
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |